{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:38:41Z","timestamp":1792589921115,"version":"4.5.0"},"reference-count":74,"publisher":"MyJove Corporation","issue":"231","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70725","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:02:30Z","timestamp":1779836550000},"source":"Crossref","is-referenced-by-count":0,"title":["Bronchoscopic Cytology and Metagenomic Sequencing to Differentiate Cancer Treatment-related and Infectious Lung Injury"],"prefix":"10.3791","author":[{"given":"Qianxue","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingbo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13014-025-02740-6","type":"journal-article","article-title":"Effects and potential mechanisms of the ultra-high dose rate radiotherapy on lung injury: a review","volume":"20","author":"Li","year":"2025","unstructured":"Li, Z. et al. Effects and potential mechanisms of the ultra-high dose rate radiotherapy on lung injury: a review. Radiat Oncol. 20 (1), 161 (2025).","journal-title":"Radiat Oncol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.3390\/ijms241210051","type":"journal-article","article-title":"Temporal and spatial patterns of inflammation and tissue injury in patients with postoperative respiratory failure after lung resection surgery: a nested case-control study","volume":"24","author":"Kormish","year":"2023","unstructured":"Kormish, J. et al. Temporal and spatial patterns of inflammation and tissue injury in patients with postoperative respiratory failure after lung resection surgery: a nested case-control study. Int J Mol Sci. 24 (12), 10051 (2023).","journal-title":"Int J Mol Sci"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.21037\/jtd-19-4000A","type":"journal-article","article-title":"Fatal toxic effects related to EGFR tyrosine kinase inhibitors based on 53 cohorts with 9,569 participants","volume":"12","author":"Xie","year":"2020","unstructured":"Xie, X. et al. Fatal toxic effects related to EGFR tyrosine kinase inhibitors based on 53 cohorts with 9,569 participants. J Thorac Dis. 12 (8), 4057-4069 (2020).","journal-title":"J Thorac Dis"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1186\/s40780-025-00522-6","type":"journal-article","article-title":"Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy","author":"Hazama","year":"2025","unstructured":"Hazama, K. et al. Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy. J Pharm Health Care Sci. doi:10.1186\/s40780-025-00522-6 (2025).","journal-title":"J Pharm Health Care Sci"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s40264-020-00968-7","type":"journal-article","article-title":"Interstitial lung disease as an adverse drug reaction in Japan: exploration of regulatory actions as a basis for high reporting","volume":"43","author":"Iwasa","year":"2020","unstructured":"Iwasa, E. et al. Interstitial lung disease as an adverse drug reaction in Japan: exploration of regulatory actions as a basis for high reporting. Drug Saf. 43 (11), 1121-1131 (2020).","journal-title":"Drug Saf"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/his.14704","type":"journal-article","article-title":"Immune checkpoint inhibitor-related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease","volume":"81","author":"Imran","year":"2022","unstructured":"Imran, S. et al. Immune checkpoint inhibitor-related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease. Histopathology. 81 (6), 724-731 (2022).","journal-title":"Histopathology"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40360-024-00821-y","type":"journal-article","article-title":"A real-world disproportionality analysis of the US Food and Drug Administration adverse event reporting system events for durvalumab","volume":"25","author":"Zou","year":"2024","unstructured":"Zou, T. et al. A real-world disproportionality analysis of the US Food and Drug Administration adverse event reporting system events for durvalumab. BMC Pharmacol Toxicol. 25 (1), 97 (2024).","journal-title":"BMC Pharmacol Toxicol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","type":"journal-article","article-title":"Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","unstructured":"Naidoo, J. et al. Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy. J Clin Oncol. 35 (7), 709-717 (2017).","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jtho.2018.08.2035","type":"journal-article","article-title":"Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors","volume":"13","author":"Suresh","year":"2018","unstructured":"Suresh, K. et al. Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors. J Thorac Oncol. 13 (12), 1930-1939 (2018).","journal-title":"J Thorac Oncol"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","type":"journal-article","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","unstructured":"Wang, D. Y. et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 4 (12), 1721-1728 (2018).","journal-title":"JAMA Oncol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S1470-2045(25)00515-7","type":"journal-article","article-title":"Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial","volume":"26","author":"Hou","year":"2025","unstructured":"Hou, Z. et al. Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 26 (12), 1552-1562 (2025).","journal-title":"Lancet Oncol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12885-021-08353-y","type":"journal-article","article-title":"Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis","volume":"21","author":"Huang","year":"2021","unstructured":"Huang, A. et al. Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis. BMC Cancer. 21 (1), 634 (2021).","journal-title":"BMC Cancer"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ccm.2024.02.006","type":"journal-article","article-title":"Drug-induced lung disease in the oncology patient: from cytotoxic agents to immunotherapy","volume":"45","author":"Shroff","year":"2024","unstructured":"Shroff, G. S. et al. Drug-induced lung disease in the oncology patient: from cytotoxic agents to immunotherapy. Clin Chest Med. 45 (2), 325-337 (2024).","journal-title":"Clin Chest Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005382-199101000-00008","type":"journal-article","article-title":"The role of chest computed tomography in the diagnosis of drug-related reactions","volume":"6","author":"Kuhlman","year":"1991","unstructured":"Kuhlman, J. E. The role of chest computed tomography in the diagnosis of drug-related reactions. J Thorac Imaging. 6 (1), 52-61 (1991).","journal-title":"J Thorac Imaging"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09553002.2025.2531903","type":"journal-article","article-title":"Advances in noninvasive imaging for detecting radiation-induced lung injury (RILI)","author":"Nissen","year":"2025","unstructured":"Nissen, A. et al. Advances in noninvasive imaging for detecting radiation-induced lung injury (RILI). Int J Radiat Biol. 1-13 (2025).","journal-title":"Int J Radiat Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.ejro.2022.100434","type":"journal-article","article-title":"Imaging features of toxicities associated with immune checkpoint inhibitors","volume":"9","author":"Gosangi","year":"2022","unstructured":"Gosangi, B. et al. Imaging features of toxicities associated with immune checkpoint inhibitors. Eur J Radiol Open. 9, 100434 (2022).","journal-title":"Eur J Radiol Open"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.2147\/JIR.S540213","type":"journal-article","article-title":"Severe community-acquired pneumonia with disseminated infection caused by highly virulent Pseudomonas aeruginosa: successful treatment of a case","volume":"18","author":"Teng","year":"2025","unstructured":"Teng, P. et al. Severe community-acquired pneumonia with disseminated infection caused by highly virulent Pseudomonas aeruginosa: successful treatment of a case. J Inflamm Res. 18, 12817-12824 (2025).","journal-title":"J Inflamm Res"},{"issue":"39","key":"ref18","doi-asserted-by":"crossref","first-page":"e44915","DOI":"10.1097\/MD.0000000000044915","type":"journal-article","article-title":"Acute fibrinous and organizing pneumonia presents as right lung upper lobe cavitary lesion: case report and literature review","volume":"104","author":"Wang","year":"2025","unstructured":"Wang, C. C. et al. Acute fibrinous and organizing pneumonia presents as right lung upper lobe cavitary lesion: case report and literature review. Medicine (Baltimore). 104 (39), e44915 (2025).","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1670456","DOI":"10.3389\/fmed.2025.1670456","type":"journal-article","article-title":"Psittacosis chlamydia pneumonia complicated with organizing pneumonia: a case report and literature review","volume":"12","author":"Li","year":"2025","unstructured":"Li, Q. et al. Psittacosis chlamydia pneumonia complicated with organizing pneumonia: a case report and literature review. Front Med (Lausanne). 12, 1670456 (2025).","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.21037\/jtd-2025-292","type":"journal-article","article-title":"Expert consensus on cancer treatment-related lung injury","volume":"17","author":"Lin","year":"2025","unstructured":"Lin, X. et al. Expert consensus on cancer treatment-related lung injury. J Thorac Dis. 17 (4), 1844-1875 (2025).","journal-title":"J Thorac Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3138\/cim-2024-0262","type":"journal-article","article-title":"Serum interleukin levels predict occurrence of acute radiation pneumonitis and overall survival in thoracic tumours","volume":"48","author":"Zhang","year":"2025","unstructured":"Zhang, Y., Shen, W. X., Li, P., Chen, M. B., Zhou, L. N. Serum interleukin levels predict occurrence of acute radiation pneumonitis and overall survival in thoracic tumours. Clin Invest Med. 48 (1), 29-38 (2025).","journal-title":"Clin Invest Med"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1667\/RADE-25-00013.1","type":"journal-article","article-title":"PNA-FISH-based chromosome aberration frequency and serum IL-6 as predictive biomarkers for radiation therapy-induced pneumonitis in lung cancer patients","volume":"204","author":"Loy-Caraos","year":"2025","unstructured":"Loy-Caraos, G. et al. PNA-FISH-based chromosome aberration frequency and serum IL-6 as predictive biomarkers for radiation therapy-induced pneumonitis in lung cancer patients. Radiat Res. 204 (2), 127-142 (2025).","journal-title":"Radiat Res"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12931-024-02917-9","type":"journal-article","article-title":"Integrated omics characterization reveals reduced cancer indicators and elevated inflammatory factors after thermal ablation in non-small cell lung cancer patients","volume":"25","author":"Zhang","year":"2024","unstructured":"Zhang, X. et al. Integrated omics characterization reveals reduced cancer indicators and elevated inflammatory factors after thermal ablation in non-small cell lung cancer patients. Respir Res. 25 (1), 309 (2024).","journal-title":"Respir Res"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"152884","DOI":"10.1016\/j.imbio.2025.152884","type":"journal-article","article-title":"Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy","volume":"230","author":"Luo","year":"2025","unstructured":"Luo, T. et al. Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy. Immunobiology. 230 (2), 152884 (2025).","journal-title":"Immunobiology"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ijrobp.2025.02.011","type":"journal-article","article-title":"Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines","volume":"122","author":"Xiao","year":"2025","unstructured":"Xiao, L. et al. Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines. Int J Radiat Oncol Biol Phys. 122 (5), 1238-1247 (2025).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"818492","DOI":"10.3389\/fimmu.2021.818492","type":"journal-article","article-title":"Comprehensive analysis of the immune microenvironment in checkpoint inhibitor pneumonitis","volume":"12","author":"Lin","year":"2021","unstructured":"Lin, X. et al. Comprehensive analysis of the immune microenvironment in checkpoint inhibitor pneumonitis. Front Immunol. 12, 818492 (2021).","journal-title":"Front Immunol"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1172\/JCI128654","type":"journal-article","article-title":"The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis","volume":"129","author":"Suresh","year":"2019","unstructured":"Suresh, K. et al. The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis. J Clin Invest. 129 (10), 4305-4315 (2019).","journal-title":"J Clin Invest"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12967-020-02650-z","type":"journal-article","article-title":"Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma","volume":"18","author":"Strippoli","year":"2020","unstructured":"Strippoli, S. et al. Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma. J Transl Med. 18 (1), 473 (2020).","journal-title":"J Transl Med"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.chest.2020.11.027","type":"journal-article","article-title":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society","volume":"159","author":"Johkoh","year":"2021","unstructured":"Johkoh, T. et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Chest. 159 (3), 1107-1125 (2021).","journal-title":"Chest"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.21037\/jtd-20-651","type":"journal-article","article-title":"Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases","volume":"12","author":"Davidson","year":"2020","unstructured":"Davidson, K. R., Ha, D. M., Schwarz, M. I., Chan, E. D. Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases. J Thorac Dis. 12 (9), 4991-5019 (2020).","journal-title":"J Thorac Dis"},{"issue":"29","key":"ref31","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1556\/650.2025.33336","type":"journal-article","article-title":"The possible role of some laboratory parameters in predicting radiation-induced lung injury after breast cancer treatment","volume":"166","author":"Ungv\u00e1ri","year":"2025","unstructured":"Ungv\u00e1ri, T. et al. The possible role of some laboratory parameters in predicting radiation-induced lung injury after breast cancer treatment. Orv Hetil. 166 (29), 1153-1159 (2025).","journal-title":"Orv Hetil"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"110053","DOI":"10.1016\/j.radonc.2023.110053","type":"journal-article","article-title":"Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease","volume":"192","author":"Park","year":"2024","unstructured":"Park, S. H. et al. Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease. Radiother Oncol. 192, 110053 (2024).","journal-title":"Radiother Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"698832","DOI":"10.3389\/fonc.2021.698832","type":"journal-article","article-title":"Peripheral blood biomarkers for early diagnosis, severity, and prognosis of checkpoint inhibitor-related pneumonitis in patients with lung cancer","volume":"11","author":"Lin","year":"2021","unstructured":"Lin, X. et al. Peripheral blood biomarkers for early diagnosis, severity, and prognosis of checkpoint inhibitor-related pneumonitis in patients with lung cancer. Front Oncol. 11, 698832 (2021).","journal-title":"Front Oncol"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"e250021","DOI":"10.1148\/rg.250021","type":"journal-article","article-title":"Pneumonia in immunocompromised patients","volume":"45","author":"Arora","year":"2025","unstructured":"Arora, S., Walker, S. M., Cummings, K. W., Hammer, M. M. Pneumonia in immunocompromised patients. Radiographics. 45 (12), e250021 (2025).","journal-title":"Radiographics"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/17476348.2020.1708720","type":"journal-article","article-title":"The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients","volume":"14","author":"Domagala-Kulawik","year":"2020","unstructured":"Domagala-Kulawik, J. The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients. Expert Rev Respir Med. 14 (3), 329-337 (2020).","journal-title":"Expert Rev Respir Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","type":"journal-article","article-title":"British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE","volume":"68","author":"Du Rand","year":"2013","unstructured":"Du Rand, I. A. et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 68 (Suppl 1), i1-i44 (2013).","journal-title":"Thorax"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1378\/chest.10-3361","type":"journal-article","article-title":"American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients","volume":"140","author":"Wahidi","year":"2011","unstructured":"Wahidi, M. M. et al. American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest. 140 (5), 1342-1350 (2011).","journal-title":"Chest"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/resp.13831","type":"journal-article","article-title":"Pulmonary alveolar proteinosis","volume":"25","author":"Jouneau","year":"2020","unstructured":"Jouneau, S., M\u00e9nard, C., Lederlin, M. Pulmonary alveolar proteinosis. Respirology. 25 (8), 816-826 (2020).","journal-title":"Respirology"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00119108","type":"journal-article","article-title":"Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage","volume":"33","author":"Maldonado","year":"2009","unstructured":"Maldonado, F., Parambil, J. G., Yi, E. S., Decker, P. A., Ryu, J. H. Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. Eur Respir J. 33 (6), 1361-1366 (2009).","journal-title":"Eur Respir J"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"e43644","DOI":"10.1371\/journal.pone.0043644","type":"journal-article","article-title":"Bronchoalveolar lavage results are independent of season, age, gender and collection site","volume":"7","author":"Olsen","year":"2012","unstructured":"Olsen, H. H., Grunewald, J., Tornling, G., Sk\u00f6ld, C. M., Eklund, A. Bronchoalveolar lavage results are independent of season, age, gender and collection site. PLoS One. 7 (8), e43644 (2012).","journal-title":"PLoS One"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","type":"journal-article","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","unstructured":"Meyer, K. C. et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 185 (9), 1004-1014 (2012).","journal-title":"Am J Respir Crit Care Med"},{"issue":"9267","key":"ref42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","type":"journal-article","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","unstructured":"Whitley, R. J., Roizman, B. Herpes simplex virus infections. Lancet. 357 (9267), 1513-1518 (2001).","journal-title":"Lancet"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3350\/cmh.2024.0416","type":"journal-article","article-title":"Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive","volume":"31","author":"Li","year":"2025","unstructured":"Li, H. et al. Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive. Clin Mol Hepatol. 31 (2), 474-488 (2025).","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12328-018-0831-y","type":"journal-article","article-title":"Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma","volume":"11","author":"Wakabayashi","year":"2018","unstructured":"Wakabayashi, S. I. et al. Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma. Clin J Gastroenterol. 11 (4), 302\u2013308 (2018).","journal-title":"Clin J Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12885-015-1385-8","type":"journal-article","article-title":"Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis","volume":"15","author":"Madrid","year":"2015","unstructured":"Madrid, F. F. et al. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis. BMC Cancer. 15, 407 (2015).","journal-title":"BMC Cancer"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.13136","type":"journal-article","article-title":"Anti-nuclear antibodies in patients with breast cancer","volume":"193","author":"Nisihara","year":"2018","unstructured":"Nisihara, R. et al. Anti-nuclear antibodies in patients with breast cancer. Clin Exp Immunol. 193 (2), 178\u2013182 (2018).","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/0973-1482.157314","type":"journal-article","article-title":"Autoantibodies in the sera of breast cancer patients: antinuclear and anti-double stranded DNA antibodies as example","volume":"11","author":"Mohammed","year":"2015","unstructured":"Mohammed, M. E., Abdelhafiz, K. Autoantibodies in the sera of breast cancer patients: antinuclear and anti-double stranded DNA antibodies as example. J Cancer Res Ther. 11 (2), 341\u2013344 (2015).","journal-title":"J Cancer Res Ther"},{"issue":"9","key":"ref48","first-page":"e18125","type":"journal-article","article-title":"Complete resolution of paraneoplastic membranous nephropathy following curative therapy of triple-negative breast cancer","volume":"13","author":"Khan","year":"2021","unstructured":"Khan, M. B., Kaur, A., Ali, A., Boris, A., Spitalewitz, S. Complete resolution of paraneoplastic membranous nephropathy following curative therapy of triple-negative breast cancer. Cureus. 13 (9), e18125 (2021).","journal-title":"Cureus"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12885-019-5701-6","type":"journal-article","article-title":"Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis","volume":"19","author":"Sun","year":"2019","unstructured":"Sun, X. et al. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis. BMC Cancer. 19 (1), 558 (2019).","journal-title":"BMC Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciy693","type":"journal-article","article-title":"Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice","volume":"67","author":"Miao","year":"2018","unstructured":"Miao, Q. et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 67 (Suppl 2), S231\u2013S240 (2018).","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"33721","DOI":"10.1038\/s41598-025-18812-2","type":"journal-article","article-title":"Metagenomic next-generation sequencing for concurrent diagnosis of infections and malignancies in patients with lung lesions: a single-center prospective study","volume":"15","author":"Chen","year":"2025","unstructured":"Chen, J. et al. Metagenomic next-generation sequencing for concurrent diagnosis of infections and malignancies in patients with lung lesions: a single-center prospective study. Sci Rep. 15 (1), 33721 (2025).","journal-title":"Sci Rep"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12941-024-00670-x","type":"journal-article","article-title":"Diagnostic strategy of metagenomic next-generation sequencing for gram negative bacteria in respiratory infections","volume":"23","author":"Liang","year":"2024","unstructured":"Liang, W. et al. Diagnostic strategy of metagenomic next-generation sequencing for gram negative bacteria in respiratory infections. Ann Clin Microbiol Antimicrob. 23 (1), 10 (2024).","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"e0129423","DOI":"10.1128\/spectrum.01294-23","type":"journal-article","article-title":"A metagenomics method for the quantitative detection of bacterial pathogens causing hospital-associated and ventilator-associated pneumonia","volume":"11","author":"Hauser","year":"2023","unstructured":"Hauser, S. et al. A metagenomics method for the quantitative detection of bacterial pathogens causing hospital-associated and ventilator-associated pneumonia. Microbiol Spectr. 11 (6), e0129423 (2023).","journal-title":"Microbiol Spectr"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fcimb.2018.00205","type":"journal-article","article-title":"Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing","volume":"8","author":"Li","year":"2018","unstructured":"Li, H. et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing. Front Cell Infect Microbiol. 8, 205 (2018).","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"e0250221","DOI":"10.1128\/spectrum.02502-21","type":"journal-article","article-title":"Application of mNGS in the etiological analysis of lower respiratory tract infections and the prediction of drug resistance","volume":"10","author":"Liu","year":"2022","unstructured":"Liu, H., Zhang, Y., Yang, J., Liu, Y., Chen, J. Application of mNGS in the etiological analysis of lower respiratory tract infections and the prediction of drug resistance. Microbiol Spectr. 10 (1), e0250221 (2022).","journal-title":"Microbiol Spectr"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-physiol-021115-105238","type":"journal-article","article-title":"The microbiome and the respiratory tract","volume":"78","author":"Dickson","year":"2016","unstructured":"Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., Huffnagle, G. B. The microbiome and the respiratory tract. Annu Rev Physiol. 78, 481\u2013504 (2016).","journal-title":"Annu Rev Physiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/IDR.S444571","type":"journal-article","article-title":"The clinical value of metagenomic next-generation sequencing in Pneumocystis jirovecii pneumonia","volume":"17","author":"Huang","year":"2024","unstructured":"Huang, M. Q., Zheng, T. T., Wang, X. R., Xiang, F. The clinical value of metagenomic next-generation sequencing in Pneumocystis jirovecii pneumonia. Infect Drug Resist. 17, 69\u201380 (2024).","journal-title":"Infect Drug Resist"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1646194","DOI":"10.3389\/fcimb.2025.1646194","type":"journal-article","article-title":"Optimization of decision thresholds for Mycobacterium tuberculosis can effectively improve the performance of mNGS in tuberculosis diagnosis","volume":"15","author":"Li","year":"2025","unstructured":"Li, Y. et al. Optimization of decision thresholds for Mycobacterium tuberculosis can effectively improve the performance of mNGS in tuberculosis diagnosis. Front Cell Infect Microbiol. 15, 1646194 (2025).","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051838","type":"journal-article","article-title":"Diagnostic role of mNGS in polymicrobial periprosthetic joint infection","volume":"12","author":"Mei","year":"2023","unstructured":"Mei, J. et al. Diagnostic role of mNGS in polymicrobial periprosthetic joint infection. J Clin Med. 12 (5), doi:10.3390\/jcm12051838 (2023).","journal-title":"J Clin Med"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12890-019-1022-4","type":"journal-article","article-title":"Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis","volume":"19","author":"Wang","year":"2019","unstructured":"Wang, J., Han, Y., Feng, J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 19 (1), 252 (2019).","journal-title":"BMC Pulm Med"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"117158","DOI":"10.1016\/j.diagmicrobio.2025.117158","type":"journal-article","article-title":"A new era in lower respiratory tract infections management: synergy between mNGS and CMTs in patients with hematological disorders","volume":"114","author":"Qiang","year":"2026","unstructured":"Qiang, P. et al. A new era in lower respiratory tract infections management: synergy between mNGS and CMTs in patients with hematological disorders. Diagn Microbiol Infect Dis. 114 (2), 117158 (2026).","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12890-024-03473-0","type":"journal-article","article-title":"Metagenomic analysis identifying a polymicrobial pulmonary infection in a non-HIV immunocompromised patient: a case report","volume":"25","author":"Duan","year":"2025","unstructured":"Duan, J. et al. Metagenomic analysis identifying a polymicrobial pulmonary infection in a non-HIV immunocompromised patient: a case report. BMC Pulm Med. 25 (1), 12 (2025).","journal-title":"BMC Pulm Med"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12941-022-00545-z","type":"journal-article","article-title":"Metagenomic next-generation sequencing contributes to the diagnosis of mixed pulmonary infection: a case report","volume":"21","author":"Qin","year":"2022","unstructured":"Qin, Z. et al. Metagenomic next-generation sequencing contributes to the diagnosis of mixed pulmonary infection: a case report. Ann Clin Microbiol Antimicrob. 21 (1), 52 (2022).","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1195629","DOI":"10.3389\/fmed.2023.1195629","type":"journal-article","article-title":"BALF metagenomic next-generation sequencing analysis in hematological malignancy patients with suspected pulmonary infection: clinical significance of negative results","volume":"10","author":"Deng","year":"2023","unstructured":"Deng, Z. et al. BALF metagenomic next-generation sequencing analysis in hematological malignancy patients with suspected pulmonary infection: clinical significance of negative results. Front Med (Lausanne). 10, 1195629 (2023).","journal-title":"Front Med (Lausanne)"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e9623","DOI":"10.7717\/peerj.9623","type":"journal-article","article-title":"Metagenomic next-generation sequencing for the clinical diagnosis and prognosis of acute respiratory distress syndrome caused by severe pneumonia: a retrospective study","volume":"8","author":"Zhang","year":"2020","unstructured":"Zhang, P. et al. Metagenomic next-generation sequencing for the clinical diagnosis and prognosis of acute respiratory distress syndrome caused by severe pneumonia: a retrospective study. PeerJ. 8, e9623 (2020).","journal-title":"PeerJ"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","type":"journal-article","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","unstructured":"Chiu, C. Y., Miller, S. A. Clinical metagenomics. Nat Rev Genet. 20 (6), 341\u2013355 (2019).","journal-title":"Nat Rev Genet"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/JCM.03050-15","type":"journal-article","article-title":"Depletion of human DNA in spiked clinical specimens for improvement of sensitivity of pathogen detection by next-generation sequencing","volume":"54","author":"Hasan","year":"2016","unstructured":"Hasan, M. R. et al. Depletion of human DNA in spiked clinical specimens for improvement of sensitivity of pathogen detection by next-generation sequencing. J Clin Microbiol. 54 (4), 919\u2013927 (2016).","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1101\/gr.238170.118","type":"journal-article","article-title":"Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid","volume":"29","author":"Miller","year":"2019","unstructured":"Miller, S. et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 29 (5), 831\u2013842 (2019).","journal-title":"Genome Res"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/cid\/ciy802","type":"journal-article","article-title":"Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children","volume":"68","author":"Zinter","year":"2019","unstructured":"Zinter, M. S. et al. Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children. Clin Infect Dis. 68 (11), 1847\u20131855 (2019).","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178003","type":"journal-article","article-title":"Status check: next-generation sequencing for infectious-disease diagnostics","volume":"134","author":"Rodino","year":"2024","unstructured":"Rodino, K. G., Simner, P. J. Status check: next-generation sequencing for infectious-disease diagnostics. J Clin Invest. 134 (4), doi:10.1172\/JCI178003 (2024).","journal-title":"J Clin Invest"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/cix881","type":"journal-article","article-title":"Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases","volume":"66","author":"Simner","year":"2018","unstructured":"Simner, P. J., Miller, S., Carroll, K. C. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 66 (5), 778\u2013788 (2018).","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12931-025-03127-7","type":"journal-article","article-title":"One-step diagnosis of infection and lung cancer using metagenomic sequencing","volume":"26","author":"Li","year":"2025","unstructured":"Li, S. et al. One-step diagnosis of infection and lung cancer using metagenomic sequencing. Respir Res. 26 (1), 48 (2025).","journal-title":"Respir Res"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1186\/s12879-024-10383-3","type":"journal-article","article-title":"Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China","volume":"24","author":"Liu","year":"2024","unstructured":"Liu, B. et al. Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China. BMC Infect Dis. 24 (1), 1475 (2024).","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13073-021-00912-z","type":"journal-article","article-title":"Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids","volume":"13","author":"Gu","year":"2021","unstructured":"Gu, W. et al. Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids. Genome Med. 13 (1), 98 (2021).","journal-title":"Genome Med"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70725\/bronchoscopic-cytology-metagenomic-sequencing-to-differentiate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:42:27Z","timestamp":1792586547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70725\/bronchoscopic-cytology-metagenomic-sequencing-to-differentiate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":74,"journal-issue":{"issue":"231","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70725","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}